BIT Pharma Announces the Presentation of NicaPlant® Phase 2 Results at International Conferences

BIT Pharma is proud to announce that the results of the Phase 2 study with NicaPlant® in aneurysmal subarachnoid haemorrhage patients will be presented at the following specialistic International Conferences:

5^th-6^th September, 2022:  9^th Annual EANS Vascular Section Meeting.  Nice, France.

8^th-12^th October, 2022: The  CNS Annual Meeting  with the theme “Neurosurgery Connected.”  San Francisco, CA. USA.

16^th-20^th  October, 2002:  EANS (European Association of  Neurosurgical Societies) Annual Meeting. Belgrade, Serbia.

Looking forward to meeting you there.